Insurer Brighthouse Financial posts Q3 profit rise, but misses estimates

Reuters
2025/11/07
Insurer Brighthouse Financial posts Q3 profit rise, but misses estimates

Overview

  • Quarterly adjusted EPS and adjusted net income rise YoY but missed analysts' expectations

  • Net income for Q3 rises significantly due to favorable actuarial adjustments

  • Brighthouse Financial announced, earlier on Thursday, co will be acquired by Aquarian Capital in $4.1 bln deal

Outlook

  • Brighthouse Financial expects to remain within RBC ratio target range of 400%-450% by year-end 2025

  • Company anticipates annual actuarial review will increase statutory reserves

Result Drivers

  • ANNUITY SALES - Record sales of Shield Level Annuities drove an 8% increase in annuity sales quarter-over-quarter

  • LIFE SALES - Life sales increased 27% quarter-over-quarter, driven by Brighthouse SmartCare

  • ACTUARIAL REVIEW IMPACT - Net income boosted by $316 mln favorable impact from annual actuarial review

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Adjusted EPS

Miss

$4.54

$5 (9 Analysts)

Q3 EPS

$7.89

Q3 Adjusted Net Income

Miss

$261 mln

$272 mln (6 Analysts)

Q3 Net Income

$453 mln

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 6 "hold" and 2 "sell" or "strong sell"

  • The average consensus recommendation for the multiline insurance & brokers peer group is "buy"

  • Wall Street's median 12-month price target for Brighthouse Financial Inc is $54.00, about 21.7% above its November 6 closing price of $65.70

  • The stock recently traded at 3 times the next 12-month earnings vs. a P/E of 2 three months ago

Press Release: ID:nBw3Tk03Fa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10